AFC-HD AMS Life Science Revenue

AFC-HD AMS Life Science had revenue of 8.43B JPY in the quarter ending February 28, 2025, with 8.63% growth. This brings the company's revenue in the last twelve months to 32.26B, up 16.55% year-over-year. In the fiscal year ending August 31, 2024, AFC-HD AMS Life Science had annual revenue of 30.19B with 18.01% growth.

Revenue (ttm)

32.26B

Revenue Growth

+16.55%

P/S Ratio

0.36

Revenue / Employee

32.45M

Employees

994

Market Cap

11.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	30.19B	4.61B	18.01%
Aug 31, 2023	25.58B	2.58B	11.23%
Aug 31, 2022	23.00B	629.00M	2.81%
Aug 31, 2021	22.37B	6.55B	41.40%
Aug 31, 2020	15.82B	-433.00M	-2.66%
Aug 31, 2019	Pro	Pro	Pro
Aug 31, 2018	Pro	Pro	Pro
Aug 31, 2017	Pro	Pro	Pro
Aug 31, 2016	Pro	Pro	Pro
Aug 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Japan Tobacco	3,149.76B
Seven & i Holdings	10.34T
Asahi Group Holdings	2,939.42B
Ajinomoto Co.	1,522.62B
Kao Corporation	1,628.45B
Pan Pacific International Holdings	2,176.10B
Unicharm	988.98B
Kirin Holdings Company	2,338.39B

Revenue Rankings